Harris Computer Corporation Acquires iMDsoft

iMDsoftiMDsoft®, a global leader in clinical information systems, today announced that it has been acquired by Harris Computer Corporation, an arm of the Constellation Software group. iMDsoft will be run as an independent business unit within Harris. It will be led by Shahar Sery, a seasoned iMDsoft executive, who has been nominated to the role of Executive Vice President.

iMDsoft's flagship product, the MetaVision® Suite, generates complete electronic patient records and provide hospitals with advanced tools for clinical workflow management and documentation, clinical assessment, care planning and decision support. Designed for high acuity environments, it delivers results in areas of the hospital with the highest cost, revenue, mortality and morbidity. It provides a single integrated record which can be accessed across departments and hospitals, giving clinicians the platform to coordinate care for their sickest patients and the data they need to make informed decisions about the best course of treatment.

Over 350 hospitals worldwide have chosen iMDsoft’s innovative technology to promote patient safety, improve financial performance, support research and compliance, and achieve sustainable market leadership. Harris will leverage iMDsoft's market-leading product and significant international presence to expand its healthcare IT product portfolio and global footprint. Harris' organizational assets and operational expertise will enable iMDsoft to enhance and strengthen their client relationships long-term.

"This investment is a tremendous vote of confidence in our team and technology," commented Shahar Sery. "We are excited about joining Harris and benefitting from the enhanced set of tools now at our disposal to serve, support and grow our customer community."

Jeff Bender, Chief Executive Officer of Harris, said: "We continue to be impressed with the product and market vision of the iMDsoft employees and believe they are a great addition to the Harris healthcare family. This is a great opportunity to add a number of marquee international customers as well as an established and proven sales distribution network. Harris and iMDsoft share the same goals - enhancing quality of care for patients and improving the financial performance of the hospital."

About Harris
Harris delivers its software solutions to over 18,000 customers across North America, and has over fifty offices from coast to coast. Since 1976, Harris has focused on providing feature-rich and robust turnkey solutions to Public Sector, Schools, Utility, and Health Care agencies. Harris' focus is on creating long-term relationships with its customers and ensuring that it meets the changing needs of its customers over time. Harris has been part of the Constellation Software Incorporated group of companies since 1996.

About iMDsoft
iMDsoft is a leading provider of Clinical Information Systems for critical, perioperative, and acute care environments. The company's flagship family of solutions, the MetaVision Suite, was first implemented in 1999. Hospitals and health networks worldwide use MetaVision to improve care quality and enhance financial results. The system promotes compliance with protocols and best practices, streamlines reporting and supports clinical research. iMDsoft is a wholly owned subsidiary of N. Harris Computer Corporation, headquartered in Wakefield, MA.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...